Bruker Balance Sheet
NASDAQ: BRKRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bruker financial position
At the end of fiscal 2025, Bruker reported total assets of $6.24 billion, up 7.5% from a year earlier against total liabilities of $3.73 billion. Shareholders' equity stood at $2.46 billion, or 39.4% of assets. The company held $298.8 million in cash and equivalents against $1.87 billion of debt, a net debt position of $1.57 billion.
The current ratio (current assets divided by current liabilities) was 1.73, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.76.
Summary generated from market data by MetaCap's automated system. Methodology
Bruker balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 298.80M | 183.40M | 488.30M | 645.50M | 1.07B | 681.80M | 678.30M | 322.40M | 325.00M | 342.40M |
| Short-Term Investments | — | — | — | 0 | 100.00M | 50.00M | 6.60M | 0 | 114.20M | 157.90M |
| Receivables | 544.90M | 565.50M | 492.00M | 472.70M | 416.90M | 335.30M | 362.20M | 357.20M | 319.30M | 243.90M |
| Inventory | 1.09B | 1.07B | 968.30M | 800.10M | 710.10M | 692.30M | 577.20M | 509.60M | 486.20M | 440.40M |
| Total Current Assets | 2.21B | 2.05B | 2.16B | 2.11B | 2.47B | 1.93B | 1.80B | 1.30B | 1.36B | 1.28B |
| Property, Plant & Equipment | 744.80M | 669.30M | 599.70M | 487.00M | 406.10M | 395.50M | 306.10M | 270.60M | 266.50M | 239.10M |
| Goodwill | 1.55B | 1.51B | 582.60M | 457.60M | 339.50M | 320.40M | 293.00M | 275.70M | 169.80M | 130.60M |
| Intangible Assets | 899.60M | 912.50M | 330.50M | 270.90M | 211.80M | 229.10M | 233.20M | 218.70M | 82.40M | 69.70M |
| Total Assets | 6.24B | 5.81B | 4.25B | 3.61B | 3.65B | 3.05B | 2.77B | 2.13B | 1.95B | 1.81B |
| Accounts Payable | 215.90M | 234.10M | 202.70M | 178.40M | 147.40M | 134.60M | 118.40M | 104.50M | 90.80M | 86.10M |
| Short-Term Debt | 16.60M | 32.50M | 121.20M | 18.70M | 112.40M | 2.20M | 500.00K | 18.50M | — | 20.10M |
| Total Current Liabilities | 1.28B | 1.28B | 1.20B | 914.30M | 938.50M | 791.90M | 645.60M | 599.30M | 524.50M | 524.70M |
| Long-Term Debt | 1.85B | 2.06B | 1.16B | 1.20B | 1.22B | 842.30M | 812.80M | 322.60M | 415.60M | 391.60M |
| Total Liabilities | 3.73B | 3.99B | 2.84B | 2.48B | 2.57B | 2.07B | 1.85B | 1.22B | 1.22B | 1.12B |
| Shareholders' Equity | 2.46B | 1.78B | 1.38B | 1.11B | 1.07B | 961.20M | 906.80M | 896.60M | 725.40M | 686.40M |
| Retained Earnings | 2.36B | 2.41B | 2.32B | 1.93B | 1.66B | 1.41B | 1.27B | 1.10B | 942.00M | 885.20M |
| Total Debt | 1.87B | 2.09B | 1.28B | 1.22B | 1.33B | 844.50M | 813.30M | 341.10M | 415.60M | 411.70M |
| Net Cash (Debt) | -1.57B | -1.91B | -793.20M | -573.70M | -166.00M | -112.70M | -128.40M | -18.70M | 23.60M | 88.60M |
| Shares Outstanding | 152.14M | 151.68M | 145.16M | 147.02M | 150.75M | 151.99M | 154.16M | 156.61M | 155.87M | 159.85M |
This table shows 10 annual periods of Bruker's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow BRKR's reporting calendar. What is a balance sheet?